Transferring pharmaceutical batch technology to continuous flow by Peterson, Olga Yuris
TRANSFERRING PHARMACEUTICAL BATCH TECHNOLOGY 


























In Partial Fulfillment 
Of the Requirements for the Degree 
Master of Science in the 













TRANSFERRING PHARMACEUTICAL BATCH TECHNOLOGY 

























Dr. Charles A. Eckert, Advisor 
School of Chemical and Biomolecular Engineering 
Georgia Institute of Technology 
 
Dr. Charles L. Liotta, Co-Advisor 
School of Chemistry and Biochemistry 
Georgia Institute of Technology 
 
Dr. Mark Styczynski 
School of Chemical and Biomolecular Engineering 




































 I would like to thank my advisors, Dr. Charles Eckert and Dr. Charles Liotta.  
They have taught me to think critically, creatively, and most of all independently.  Thank 
you to the past and present members of the Eckert/Liotta group for their support and 
friendship.  Thank you to Kristen Kitigawa, Kyle Flack, Rani Jha, Elizabeth Cope, and 
Pamela Pollet for helping develop my laboratory skills and acting as my sounding board.  
Thank you to Gregory Marus, Ryan Hart, and Ali Fadhel for being my mentors and close 
friends.   
 Finally, I would like to thank my family. Without their support I would never 
have made it this far.  Thank you to my parents for being my first and oldest teachers and 

















TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS iv 
LIST OF TABLES vii 
LIST OF FIGURES viii 
SUMMARY x 
CHAPTER 
1 Introduction 1 
2 Experimental 6 
2.1 Materials 6 
2.2 Equipment 6 
2.3 Experimental Methods 9 
3 Results and Discussion 14 
3.1 Meerwein-Pondorf-Verley (MPV) Reduction Reaction 14 
3.2 Batch MPV Reduction Reactions 17 
 3.2.1 Benzaldehyde 17 
 3.2.2 Acetophenone 20 
3.3 Continuous Flow Experiments 21 
4 Conclusions 28 
5 Recommendations 29 
5.1 Hemetsberger Indolization Reaction 29 
5.2 Phase Transfer Catalysis 30 
5.3 Continuous Flow System 31 
APPENDIX A: Batch Experimental Procedure 33 
 vi 
APPENDIX B: Continuous Flow Experimental Procedure 35 
APPENDIX C: Proposed MPV Reduction of Benzaldehyde Mechanism 37 
APPENDIX D: 
1
H NMR Data for Aggregation States of Catalysts 38 
REFERENCES 40 
 vii 
LIST OF TABLES 
Page 
Table 3.1: Pseudo 1
st
 order estimate apparent rate constants for MPV reactions 20 
Table A.1: Stock Solution Preparation for Batch Reactions 33 
Table A.2: Example Batch Reaction Sampling Guide 34 
Table B.1: Stock Solution Preparation for Continuous Flow Reactions 35 




LIST OF FIGURES 
Page 
Figure 1.1: The MPV reduction of (S)-CMK 4 
Figure 2.1: The mixing and linear reactor modules of the Corning® glass reactor 7 
Figure 2.2: The 8 module configuration of the continuous flow system 8 
Figure 2.3: The hood installation of the entire continuous flow system 8 
Figure 2.4: Radleys Carousel 12 Reaction Station 9 
Figure 2.5: HPLC calibration curves for the MPV reaction reagents and products 11, 12 
Figure 3.1: The MPV reduction of (S)-CMK to (S,R) and (S,S)-CMA 14 
Figure 3.2: The MPV reduction of (S)-CMK using Al(OtBu)3 and Al(OiPr)3 15 
Figure 3.3: The MPV reduction of (S)-CMK in a 9:1 toluene/isopropanol  
 solvent mixture using Al(OtBu)3 and Al(OiPr)3 16 
Figure 3.4: The MPV reduction of (S)-CMK at various Al(OtBu)3 loadings 17 
Figure 3.5: The modified MPV reduction scheme for benzaldehyde 18 










Figure 3.8: The simplified rate of reaction for the MPV reduction on benzaldehyde 19 
Figure 3.9: The acetophenone MPV reduction scheme 20 
Figure 3.10: Batch MPV reduction of acetophenone at 80
o
C and 20mol% Al(OtBu)3 21 
Figure 3.11: Configuration of the continuous flow system: two mixing modules 22 
Figure 3.12: Continuous flow (2 modules) MPV reduction of benzaldehyde 22 
Figure 3.13: Configuration of the continuous flow system: eight modules 23 

























Figure 5.1: Hemetsberger indolization reaction of (Z)-ethyl 2 azido-3-phenylacrylate 29 
Figure 5.2: The multi-injection continuous flow system configuration 30 
Figure 5.3: PTC elimination reaction of (2-bromoethyl)benzene 30 
Figure 5.4: The continuous flow system configuration for PTC reactions 31 
Figure 5.5: Temperature-pressure (
o
C, Bar) boundary conditions for the reaction path 32 
Figure 5.6: Temperature-pressure (
o
C, Bar) boundary conditions for PFA tubing 32 
Figure C.1: Mechanism for the MPV reduction of benzaldehyde using Al(OtBu)3 37 
Figure D.1: 
1
H NMR for Al(OtBu)3 in benzene 38 
Figure D.2: 
1






The current trend in the pharmaceutical industry is towards continuous flow 
processes.  Continuous flow reactor technology can produce a cheaper, better quality 
product at reduced energy and environmental cost through more efficient mass and heat 
transfer. It also enables a simplified and faster approach to bulk production by scaling out 
as opposed to scaling up.  The research presented here focuses on the configuration and 
installation of a continuous flow system into the laboratory, and the transfer of a 
Meerwein-Ponndorf-Verley (MPV) reduction from batch to continuous mode.   
The Corning® glass continuous flow reactor in our laboratory utilizes specially-
designed mixing structures for enhanced mass transfer.  Additionally, the glass reactor 
offers nonreactivity and corrosion resistance over a wide range of temperature and 
pressure, which conventional steel reactors do not allow.  The MPV reduction is a well-
known method to prepare primary and secondary alcohols from aldehydes and ketones, 
respectively.  The traditional MPV reduction protocol (Al(OiPr)3 in isopropanol) was 
modified to enable the technological transfer from batch to continuous mode.  This is the 
first time MPV reduction reactions were carried out in continuous mode.  As a result, the 
MPV reduction of the model compound, benzaldehyde, was successfully conducted with 
60% less catalyst and product yield was improved up to 20% (average of 10%) in 
continuous flow reactions as compared to current batch technology. These results are 
being used to develop a technology roadmap for the pharmaceutical industry to 






The goal in industry is to produce a lower cost, higher quality product by 
increasing the overall reaction conversion and selectivity over side-products. 
[1,2]
 
Continuous flow processes can out-perform conventional batch processes through 
enhanced mixing and temperature control. 
[3]
   In the pharmaceutical industry continuous 
flow processes are often scaled-out vs. scaled-up to meet an industrial production demand 
which shortens the product development life cycle. 
[1]
 Issues that arise from conventional 
scale-up such as safety concerns, reaction modification and equipment design, as well as 
the lengthy delays of pilot plant tests, are avoided by numbering-up in continuous 
processes.   
Enhanced heat transfer in continuous flow reactors is particularly relevant.  
Overheating of exothermic reactions due to insufficient cooling can lead to substantial 
side-product formation outside a tight temperature range; and explosive situations.  
Kockmann and Roberge from Lonza 
[4]
 utilized multi-injection principle to transfer a 
Grignard reaction to continuous mode.  They chose phenylethyl magnesium bromide 
(Grignard) and 2-chloropropionyl chloride (acyl-Cl) for the reaction because this system 
is very sensitive to side-product formation.  They demonstrated that continuous mode 
multi-injection and good heat transfer reduce hot-spots in the reaction system, increasing 
the desired product yield from 22% (one continuous flow inlets) to 38% (six continuous 
flow inlets).  They also demonstrated the thermal nature of the reaction, noting that with 
sufficient cooling, the flow rate has only a small influence on the desired product yield.   
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The improved thermal control is also important for endothermic reactions, which 
may shut down due to the lower temperatures caused by insufficient heating.  Moreover, 
if a reaction is equilibrium limited insufficient heat transfer will decrease the equilibrium 
conversion for both exothermic and endothermic reactions. 
Nitration reactions are performed under highly dilute conditions in batch due to 
the exothermic nature (explosion potential) of organic nitrates, making the process 
difficult to scale-up in industry.  Ducry and Roberge 
[5]
 investigated the nitrous acid-
catalyzed nitration of phenol.  The autocatalytic nature of phenol nitration can result in a 
thermal runaway scenario.  Continuous flow phenol nitration resulted in reduced 
polymeric side products and up to 20% higher yields when compared to batch reactions 
(<1 L).  The reaction was then intensified, performed virtually solvent-free (10% water to 
liquefy phenol; and water in the acid).  Under these conditions, the polymeric compound 
formation decreased by a factor of 10 when compared to batch experiments.  The best 
yield of the desired products using the intensified procedure was 77%.   
Enhanced mass transfer in continuous flow reactors is particularly relevant for 
crystallization reactions.  Crystal structure and size dictate the properties of the 
compound.  Precise mixing controls the size and size distribution of crystals.  Panagiotou 
et al.
[6]
 employed continuous microfluidic reaction technology to produce submicrometer 
active pharmaceutical intermediate (API) particles.  The API was norfloxacin an 
antibacterial agent, and the solvent/antisolvent system comprised of dimethylsulfoxide 
and water.  Continuous flow experiments resulted in mean particle sizes of 320 nm (60 
MPa) to 200 nm (140 MPa).  The conventional process (crystallization at low shear 
followed by repeated microfluidizer processing) resulted in a median particle size of 428 
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nm (207 MPa).  The continuous microfluidic technology resulted in substantially smaller 
particles and required 23 times less processing, which correlates to shorter processing 
time and energy efficiency.  
The fine chemical and pharmaceutical industries need modular reactors that meet 
various physico-chemical characteristics (temperature, pressure, and chemical resistance) 
of synthetic reactions that can be assembled depending on the reaction type being 
investigated. 
[1,7]
  The Corning® glass continuous flow reactor in our laboratory is a 
modular reactor.  It is compatible with a wide range of chemicals and solvents; and 




C) and pressure (up to 









, and precipitation reactions
[11]
. 
We investigated the Corning® continuous flow reactor for Meerwein-Ponndorf-
Verley (MPV) reduction.  The MPV reduction is used a great deal in industry 
[12, 13]
 
because the reagents are low cost and the reaction is simple and chemoselective.
[14, 15]  
For 
example, it is employed in the synthesis of HIV protease inhibitors such as Saquinavir®, 
Amprenavir®, and Atazanavir®. 
[16, 17, 18]
 However, a large amount of the conventional 
catalyst, Al(OiPr)3 is needed to achieve high yields in reasonable time.  A key 
intermediate for HIV protease inhibitors is industrially produces by the batch MPV 
reduction of N-Boc-(3S)-3-amino-1-chloro-4-phenyl-2 butanone (CMK) at 50
o
C, 50 
mol% Al(OiPr)3 loading, in isopropanol, and a 3 hour reaction time (Figure 1.1). 
Previous investigations into batch MPV reduction of (S)-CMK in our group developed a 
new catalyst, Al(OtBu)3 that resulted in a dramatic rate enhancement of the MPV 
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reduction over the industrial standard Al(OiPr)3 catalyst.  The development of the 
Al(OtBu)3 catalyst enabled the transfer of the batch MPV reaction to continuous mode. 
 
 
Figure 1.1 The MPV reduction of (S)-CMK. 
 
The first step in our investigation was the configuration and installation of a 
continuous flow system into our laboratory.  The Corning® glass reactor was configured 
with two heat exchangers, two syringe pumps, flow meters, pressure gauges, 
thermocouples, and pressure relief valves; and tested for leaks (reaction and heat 
exchanger).  The entire system was then installed inside a floor-to-ceiling hood.  It is 
important to note that the entire system is accessible while in the hood.  The pumps and 
heat exchangers can be removed for maintenance and the Corning® reactor can be 
reconfigured if desired.  All the flows of the system (reaction and heat exchanger) were 
labeled, and system pressure and temperature limits were posted.    
The second step was the batch optimization of the MPV reduction of a two model 
compounds, benzaldehyde (aldehyde) and acetophenone (ketone).  The traditional MPV 
reduction protocol (Al(OiPr)3 in isopropanol) was modified; Al(OtBu)3 catalyst was used 
because it speeds up the reaction, and a solvent mixture (2:3) of isopropanol and toluene 
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was used to increase the solubility of Al(OtBu)3.  The effect of catalyst (5 and 20 mol%) 
loading and reaction temperature (65 and 80
o
C) on product yield was determined. 
The MPV reduction of benzaldehyde was then transferred to the Corning® 
reactor.  The reactor was configured with two feeds: the benzaldehyde dissolved in 
isopropanol and the catalyst dissolved in toluene.  Experimental procedures were 
developed to ensure reproducibility.  Internal standards were added to the stock solutions: 
dodecane (benzaldehyde solution) and nonane (catalyst solution).  System equilibrium 
experiments were carried out to determine when to start sampling.  The effect of catalyst 
(5 and 20 mol%) loading, reaction temperature (65 and 80
o
C), and residence time (2, 4 






Anhydrous isopropanol, anhydrous toluene, nonane, dodecane, industrial grade 
Al(OtBu)3, benzaldehyde, benzyl alcohol, and 1-phenylethanol where purchased from 
Sigma Aldrich and used as received.  Reagent grade methanol was purchased from VWR 
and used as received.  Concentrated hydrochloric acid was purchased from VWR and was 
diluted to 2M.  Acetophenone was purchased from Sigma Aldrich and vacuum distilled 
(99.9% by HPLC).  
2.2 Equipment 
We are employing a versatile glass continuous flow reactor developed by 
Corning®.  The borosilicate glass construction is compatible with a wide range of 





C) and pressure (up to 18 bar).  Corning has specifically engineered mixing 
reactor modules for heterogeneous systems which optimize mixing.  Linear reactor 
modules are used for heating or cooling and residence time (Figure 2.1).  All of the 




C, up to 3 bar).  
As a consequence, these reactor modules facilitate an optimum surface-to-volume ratio 
for improved heat transfer.   
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Mixing Module Linear Module
 
Figure 2.1 The mixing and linear reactor modules of the Corning® glass reactor. 
 
The Corning® continuous flow glass reactor in our laboratory is modular.  It is 
made of nine reactor modules (5 mixing and 4 linear), three temperature regions and six 
possible inlets.  The reactor is versatile, enabling multistep synthesis including: reagent 
pre-heating, pre-cooling and reaction quenching.  
Our system (Figure 2.2), which includes two ISCO 500D Syringe Pumps and two 
heat exchangers (a LAUDA Integral XT150 and a Thermo Election Corp. NESLAB 
RTE7), is housed in a floor-to-ceiling hood in our laboratory (Figure 2.3).  Pump flow 
rates are monitored using flow meters (Omega, PTFE construction and sapphire float).  
The system pressure is measured using pressure gauges (Matheson, 316 stainless steel, 0-










Figure 2.3 The hood installation of the entire continuous flow system. 
 
The batch experiments were carried out in a Radleys Carousel 12 Reaction Station 
to ensure consistent reaction conditions (Figure 2.4).  The carousel design allows for 
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simultaneous heating, stirring and refluxing of 12 reactions (1 to 20 mL total volume) 
under inert atmosphere.  The carousel stirring hotplate has a temperature range from 




C) and ensures equal stirring at all 12 positions. The 
integrated reflux head of the carousel system is controlled by a heat exchanger (Thermo 
Election Corp., NESLAB RTE7) to reduce solvent evaporation and subsequent loss.  
 
 
Figure 2.4 Radleys Carousel 12 Reaction Station. 
 
For reaction monitoring and analysis an Agilent Series 1100 LC with UV-vis 
detector was used.  A Luna 5µ, C18 column was used and the HPLC solvents are 
acetonitrile and water (0.1 vol% trifluoroacetic acid in water).  For continuous flow 
experiments, the internal standards nonane and dodecane were analyzed using an Agilent 
6890 series GC with FID detector.  A HP-5 column 30m x 0.25 mm and 0.25 µm was 
used and helium was the carrier gas. 
 
2.3 Experimental Methods 
All continuous flow reactions were performed using the continuous flow system 
in Figure 2.3. Stock solutions of the reagents were prepared under anhydrous conditions.  
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A 0.75 mmol/mL solution of benzaldehyde in isopropanol was made and 1.0 vol% 
dodecane was added to the solution to make the final stock solution.  For 20 mol% 
catalyst loading experiments, a 0.11 mmol/mL solution of Al(OtBu)3 in toluene was 
made and 1.0 vol% nonane was add to the solution to make the final stock solution.  For 
5 mol% catalyst loading experiments, a 0.03mmol/mL solution of Al(OtBu)3 in toluene 
was made and 1.0 vol% nonane was add to the solution to make the final stock solution. 
The hydrocarbons dodecane and nonane act as internal standards; they do not participate 
in the reaction.  Solids were weighed out using a balance (Mettler Toledo, AT21 
DeltaRage ®, ± 0.001g).  Liquid compounds were measured using NORM-JECT luer 
lock syringes and Eppendorf research pipettes.   
From Figure 2.2, ISCO 2 delivers the catalyst in toluene and ISCO 1 delivers the 
substrate in alcohol.  Before initializing the flow experiments, the piston pumps were 
loaded with the reagent and catalyst stock solutions.  A filter (Swagelok, 140 micron) was 
used when loading the catalyst stock solution.  The ISCO reservoirs do not have mixing, 
so before each flow rate experiment a “0 sample” of the reagent solutions was collected 
after the flow meter to account for any concentration gradient in the reservoir.  The ISCO 
pumps continuously delivered the stock solutions to the Corning® reactor at a 2:3 
volume ratio of reagent to catalyst.  The system was allowed to equilibrate for two reactor 
volumes at the set flow rate before collecting samples.  After equilibrium, three reaction 
samples were collected, one reactor volume apart, and averaged to calculate experimental 
error.   
For organic content analysis, 1.0 mL of the collected reaction sample was cooled 
in an ice bath, quenched with 0.4 mL of 2M HCl for 5min and then diluted with 16 mL of 
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methanol.  The quenched reaction solutions were then diluted 10:1 for HPLC analysis. 
This dilution was repeated twice.  The disappearance of starting material and appearance 
of product was quantified using calibration curves as follow: benzaldehyde at 254λ and 
2.64 min, R
2
= 0.999; benzyl alcohol at 210λ and 1.73 min, R
2
 = 0.999; acetophenone at 
210λ and 2.72 min, R
2
 = 0.994; and 1-phenylethanol at 210λ and 2.03 min, R
2
 = 0.987.  
Figure 2.5 shows the calibration curves that were used. 
 



































































































Figure 2.5 Continued. 
 
The internal standards, nonane and dodecane were monitored by GC from a 1.0 
mL sample collected from reaction (nonane at 2.9 min, dodecane at 7.9 min).  The ratio 
of the internal standard peak area after reaction to that before reaction (“0 samples”) 
allows us to accurately track the volume ratio the two piston pumps are achieving.  This 
ratio was used to calculate the amount of benzaldehyde available for reaction and 
accurately calculate yield and conversion when combined with the HPLC data. 
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All batch reactions were performed using the Radleys carousel systems in Figure 
2.4. Stock solutions of the reagents were prepared under anhydrous conditions.  A 
0.75mmol/mL stock solution of benzaldehyde in isopropanol was made (0.78 mmol/mL 
acetophenone).  For 20 mol% catalyst loading experiments, a 0.11 mmol/mL stock 
solution of Al(OtBu)3 in toluene was made (0.11 mmol/mL Al(OtBu)3 for acetophenone 
experiments).  For 5 mol% catalyst loading experiments, a 0.03 mmol/mL solution of 
Al(OtBu)3 in toluene was made.  The batch reactions all had a total reaction volume of 5 
mL and a 2:3 volume ratio of reagent to catalyst.  To stop the reaction, the entire reaction 
volume was cooled in an ice bath and then quenched with 2mL of 2M HCl for 5 min, 
before being diluted with 30mL of methanol.  The quenched reaction solution was then 
diluted 10:1 for HPLC analysis.  The organic content was quantified using the calibration 
curves in Figure 2.5. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
 
3.1 Meerwein-Pondorf-Verley (MPV) Reduction Reaction 
The MPV reduction reaction is widely used in industry 
[14, 15]
 because the 
reagents, Al(OiPr)3 and isopropanol, are low cost and the reaction is chemoselective.
[9, 10]  
For example, it is employed in the synthesis of HIV protease inhibitors such as 
Saqqinavir®, Amprenavir®, and Atazanavir®. 
[6, 12, 13]
  A key intermediate for these HIV 
protease inhibitors is produced on an industrial scale by the batch MPV reduction of N-
Boc-(3S)-3-amino-1-chloro-4-phenyl-2 butanone (CMK) at 50
o
C, 50 mol% Al(OiPr)3 
loading, in isopropanol, and 3 hour (Figure 3.1). 
 
 
Figure 3.1 The MPV reduction of (S)-CMK to (S,R) and (S,S)-CMA. 
 
Previous research in our group into the MPV reduction of CMK, resulted in the 
discovery that the rate of reduction is drastically increased when Al(OtBu)3 replaces the 
traditional Al(OiPr)3 catalyst (Figure 3.2).  The MPV reaction catalyzed by Al(OtBu)3 is 
complete after 15 min, while the analogous Al(OiPr)3 catalyzed reaction reaches 
completion after 2 hours.  Because t-butoxide ligands do not have alpha hydrogen, the 
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reaction can only take place upon ligand exchange with isopropanol. However, the rate 
enhancement is attributed to the difference in aggregation state between the Al(OtBu)3 
(dimeric) versus the Al(OiPr)3, which is tetrameric. The reactions were also conducted in 
a 9:1 toluene/isopropanol solvent mixture (Figure 3.3).  Again, the Al(OtBu)3 catalyzed 
reactions showed higher activity than Al(OiPr)3, but as expected due to dilution effect, 
the MPV reduction in toluene required about twice as long to achieve the same product 

















































Figure 3.3 The MPV reduction of (S)-CMK in a 9:1 toluene/isopropanol solvent mixture using 
Al(OtBu)3 and Al(OiPr)3. 
 
The rate enhancement allowed for the amount of catalyst to be reduced for the 
reaction to take place on the same time scale as the Al(OiPr)3. Catalyst loading was 
investigated in the MPV reduction of (S)-CMK on a 5 mL reaction scale in a carousel 
reactor. 50, 40, 30, 20, 10, and 5 mol % were compared using Al(OtBu)3 in isopropanol 
at 50
o
C (Figure 3.4).  Catalyst loadings from 50 to 20mol% show similar reaction rates. 



























Figure 3.4 The MPV reduction of (S)-CMK at various Al(OtBu)3 loadings. 
 
 
3.2 Batch MPV Reduction Reactions 
3.2.1 Benzaldehyde 
The traditional MPV reduction protocol (Al(OiPr)3 in isopropanol) was modified 
to enable the technological transfer from batch to continuous mode.  All batch and 
continuous mode reactions discussed here used Al(OtBu)3 and a 3:2 volume ratio of 
toluene to isopropanol.  The Al(OtBu)3 increased the rate of reaction and the solvent 
mixture increased the solubility of the catalyst. The MPV reduction of the model 
compound benzaldehyde (Figure 3.5) was investigated at two catalyst loadings (20 and 5 
mol%) and two reaction temperatures (65 and 80
o
C).  At 20 mol% and 80
o
C, the reaction 
is complete after 12 min; therefore increasing the temperature by 15
o
C increased the 
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product yield by an average 25% (Figure 3.6).  At 5 mol% catalyst loading, increasing the 
temperature by 15
o
C increased the product yield by an average 15% (Figure 3.7).   The 5 
mol% reactions do not go to completion as seen in Figure 3.7.  This may be due to any 
inherent moisture in the system causing the hydrolysis of the Al(OtBu)3.  But, at an order 
of magnitude lower catalyst loading than the industrial protocol, the reaction reached 
80% yield in 35 min. 
 
 



























































 order kinetic analysis was performed on the batch kinetic data in 
Figures 3.6 and 3.7 to estimate the apparent rate constant for the MPV reduction of 
benzaldehyde at the various reaction conditions.  The simplified rate of reaction equation 
(Figure 3.8) and the integral method analysis resulted in Table 3.1.  Increasing the 
reaction temperature by 15
o
C (keeping all other reaction conditions the same), increases 
the apparent rate constant two fold, whereas increasing the catalyst loading by 15 mol%, 









Table 3.1 Pseudo 1
st




















The MPV reduction of the second model compound, acetophenone, was 
investigated. Because ketones are known to react more slowly under MPV conditions 
than aldehydes, the investigation was started with the optimized reaction conditions of 20 
mol% Al(OtBu)3 and 80
o
C (Figure 3.9).  The MPV reduction of acetophenone reaches 
70% yield after one hour (Figure 3.10).   
 
 





















Figure 3.10 Batch MPV reduction of acetophenone at 80
o
C and 20mol% Al(OtBu)3. 
 
3.3 Continuous Flow Experiments 
Two reactor configurations were investigated for the MPV reduction of 
benzaldehyde.  The initial configuration included two mixing modules (reactor volume of 
16 mL) (Figure 3.11).  Five residence times were investigated; 3, 1, 0.5, 0.27 and 0.18 
min, corresponding to total flow rates of 5, 15, 30, 60 and 90 mL/min, at 65
o
C and 20 
mol% Al(OtBu)3 (Figure 3.12).  From the results we can see that reducing the total flow 
rate (increasing residence time), increases yield up to 46% at 3 min (the longest residence 



























Figure 3.12 Continuous flow (2 modules) MPV reduction of benzaldehyde: 65
o
C, 20mol%, 5 




The final reactor configuration utilizes 8 reactor modules (5 mixing and 3 linear 
modules), and incorporates preheating of the reagent streams (Figure 3.13). With this 
configuration, the reactor volume was increased to 48 mL (considering only modules 
where reaction is occurring).  The residence times investigated were 2, 4 and 11 min 
correspond to flow rates of 30, 15 and 5 mL/min, respectively. Internal standards were 
introduced to the reagent stock solutions in 1 vol% to accurately measure flow rates.  The 







Figure 3.13 Configuration of the continuous flow system: eight modules. 
 
From Figure 3.14, we can see that increasing the residence time and temperature 
of the reaction increased product yield, from 44% yield (20 mol% Al(OtBu)3, 2min 
residence time and 65
o
C) up to 98% yield (at 20 mol% Al(OtBu)3, 11 min residence time 
and 80
o
C). When we compare the continuous flow results (red circles) with batch (blue 
squares), the continuous reactor exhibits a significant yield enhancement at shorter 
reaction times (Figure 3.15). Specifically, the yield increases by up to 20% at a residence 
 24 




C.  The yield increase observed with 
the continuous reactor was attributed to enhanced mixing in the continuous flow reactor 



















































































The reduction in catalyst loading to 5 mol % was studied for the MPV reduction 




C and 11 min residence time (Figure 3.16).  When we compare the continuous flow 
results with batch (identical reaction conditions), we again observe significant yield 
enhancement (Figure 3.17).  The yield increases by up to 10% at the two shortest 






























































































We have configured and installed a Corning® glass continuous flow system into a 
floor-to-ceiling hood in our laboratory.  The hood installation allows for future 
investigations of high temperature reactions and reactions with hazardous reagents.  The 
system flow and pressure can be monitored during reaction to ensure normal operation 
and reaction.  We have developed experimental procedures for continuous flow reactions 
by successfully transferring a batch MPV reduction to continuous mode.  This is the first 
time a MPV reduction were carried out in continuous mode.  The MPV reduction of the 
model compound, benzaldehyde, was successfully conducted with 60% less catalyst than 
in the industrial batch protocol and product yield was improved up to 20% for 20 mol% 
Al(OtBu)3 continuous flow experiments and up to 10% for 5 mol% Al(OtBu)3 continuous 
flow experiments as compared to batch experiments.  Industrially, this is significant as it 
means coast savings and a reduction of the metal-contaminated waste stream.  These 
results are being used to develop a technology roadmap for the pharmaceutical industry 





5.1 Hemetsberger Indolization Reaction 
Indole containing compound are important in the pharmaceutical industry because 
they are precursors for many bioactive molecules.  The Hemetsberger reaction involves 
the slow addition of the azido-precursor solution into refluxing toluene (110
o
C), inducing 
the formation of the indole ring via the formation of a reactive nitrene intermediate 
(Figure 5.1)
[19]
.  The intermediate nitrene in this reaction is highly reactive and 
decomposes readily and the loss of nitrogen is an exothermic reaction.  The Corning® 
reactor can be a distinct advantage to maintaining a very narrow temperature range and 
good mixing throughout the experiment to ensure a high yield and reproducibility.  
 
 
Figure 5.1 Hemetsberger indolization reaction of (Z)-ethyl 2-azido-3-phenylacrylate. 
 
Operating the Corning® continuous flow reactor with multiple inlets (Figure 5.2) 
mimics the batch Hemetsberger reaction procedures.  ISCO 1 delivers toluene which is 
preheated to 110
o






Figure 5.2 The multi-injection continuous flow system configuration. 
 
5.2 Phase Transfer Catalysis 
The enhanced mass transfer in the specifically designed Corning® continuous 
reactor can be taken advantage of by running a liquid-liquid Phase Transfer Catalysis 
(PTC) reaction (Figure 5.3)
[20,21]
.  PTC is a technique for conducting reactions between 
reagents that are not miscible with each other. Therefore, the phase transfer catalyst 
transfers reagent(s) into the reaction phase and the products back out into the supply 
phase. This approach is widely used to manufacture polymers, pharmaceuticals, 
agricultural products and petrochemicals.  There are multiple benefits to employing PTC 
reactions: (1) use of benign solvents, (2) lower costs, (3) shorter reaction times and lower 




Figure 5.3 PTC elimination reaction of (2-bromoethyl)benzene. 
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To take advantage of all the specially designed mixing modules of the Corning® 
reactor, I propose the following configuration (Figure 5.4). ISCO 1 delivers the organic 
phase containing (2-bromoethyl)benzene, tetrabutyl ammonium chloride (PTC catalyst) 
in toluene; ISCO 2 delivers the aqueous phase containing sodium hydroxide in water.  





Figure 5.4 The continuous flow system configuration for PTC reactions.  
 
5.3 Continuous Flow System 
It will be beneficial to install a back-pressure regulator on our current system. The 
Corning® glass continuous flow reactor can withstand a considerable pressure over a 
wide temperature range (Figure 5.5 and Figure 5.6).  Installing a back-pressure regulator 
would allow us to take advantage of this feature for gas-liquid reactions in the 
pharmaceutical and fine chemical industries. 
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Figure 5.5 Temperature-pressure (
o
C, Bar) boundary conditions for the reaction path.  
 
Figure 5.6 Temperature-pressure (
o
C, Bar) boundary conditions for PFA tubing (inlet, outlet, 
and heat exchanger system).  
 33 
APPENDIX A 
BATCH EXPERIMENTAL PROCEDURE 
 
Table A.1 Stock Solution Preparation for Batch Reactions. 
Benzaldehyde Stock 
 




Isopropanol, Anhydrous 30 mL 
 
Toluene, Anhydrous 40 mL 
Benzaldehyde 2.5 mL 
 
Al(OtBu)3 0.2669 g 
     Acetophenone Stock 
 




Isopropanol, Anhydrous 3 mL 
 
Toluene, Anhydrous 3 mL 
Acetophenone 30 mL 
 
Al(OtBu)3 0.0810 g 
 
  
Make stock solutions under inert atmosphere (Table A.1).  Add 3 mL of the catalyst stock 
solutions to the carousel test tubes.  Heat the reaction tubes with catalyst stock to the 
desired reaction temperature; wait for the temperature to stabilize.  Add 2 mL of the 
reagent (benzaldehyde/acetophenone) stock solution to the reaction tubes at timed 
intervals.  To quench the reaction, remove the reaction tube from the carousel and cool in 
an ice bath (test tube rack in ice bath on a stir plate) until cool to the touch, then add 2 mL 
of 2M HCl and let stir in ice bath for 5 min (Table A.2).  Dilute the reaction mixture with 
30mL of methanol.  HPLC samples for the MPV reduction of benzaldehyde are made by 
adding 100 uL of the sample to 900uL of methanol in a GC vial.  Acetophenone MPV 
reduction reactions require two different dilutions to make sure the peak areas of 
acetophenone and 1-phenylethanol are within the HPLC calibration curve ranges.  HPLC 
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samples for the MPV reduction of acetophenone are made by adding 250 uL sample to 
750 uL methanol and 750 uL sample to 250 uL methanol. 
 
















1   0 36   36   41 5 
2   1 34   33   39 5 
3   2 32   30   37 5 
4   3 30   27   35 5 
5   4 28   24   33 5 
6   5 26   21   31 5 
7   6 24   18   29 5 
8   7 22   15   27 5 
9   8 20   12   25 5 
10   9 18   9   23 5 
11   10 16   6   21 5 




CONTINUOUS FLOW EXPERIMENTAL PROCEDURE 
 
Table B.1 Stock Solution Preparation for Continuous Flow Reactions. 
Benzaldehyde Stock 
Reagent Amount 
Isopropanol, Anhydrous 500 mL 
Benzaldehyde 43 mL 
Dodecane 5.4 mL 
  
5 mol% Al(OtBu)3 Stock 
Reagent Amount 
Toluene, Anhydrous 600 mL 
Al(OtBu)3 3.8 g 
Nonane 6 mL 
  
20 mol% Al(OtBu)3 Stock 
Reagent Amount 
Toluene, Anhydrous 600 mL 
Al(OtBu)3 15.5 g 




Make stock solutions under inert atmosphere (Table B.1).  Collect 1 mL stock 
solution samples for GC analysis (“cat stock”, “BA stock”) out of the flasks.  Preheat the 
reactor to desired reaction temperature; wait for the temperature to stabilize.  Use the 
filter when loading the catalyst stock solution into ISCO 2.  Collect “0 sample” by 
disconnecting at the bottom of the flow meter in the ISCO 1 line.  Dilute 0.5 mL of the “0 
sample” with 20 mL of methanol and then make HPLC samples by adding 100 uL of the 
diluted sample to 900 uL methanol in a GC vial.   
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Wait two reactor volumes before collecting samples (system stabilized) and collect 
samples every reaction volume after that  (Table B.2).  The GC samples are made by 
adding 1 mL of the collected reaction mixture to a GC vial (no dilution).  To quench the 
reaction, add 1mL of the collected reaction mixture to 1mL of cold methanol, let stir until 
cooled.  Then add 0.4 mL of 2M HCl and let stir for 5 min.  Dilute the quenched reaction 
mixture with an additional 15 mL of methanol. Make HPLC samples by adding 100uL of 
the diluted, quenched reaction mixture to 900 uL of methanol in a GC vial. 
At the end of the experiment, rinse the ISCO pumps and reactor with isopropanol 
(ISCO 1) and toluene (ISCO 2), and cool the heat exchangers to room temperature.   
 





































0 0 0 0  0 : 00 : 00
LAUDA Set Point= 86.8 C 1 56 672 11.20  0 : 11 : 12
82.9 C 2 112 1344 22.40  0 : 22 : 24
Vol. Cat= 3 168 2016 33.60  0 : 33 : 36





































0 0 0 0  0 : 00 : 00
LAUDA Set Point= 86.8 C 1 56 224 3.73  0 : 3 : 44
82.9 C 2 112 448 7.47  0 : 7 : 29
Vol. Cat= 3 168 672 11.20  0 : 11 : 12





































0 0 0 0  0 : 00 : 00
LAUDA Set Point= 86.8 C 1 56 112 1.87  0 : 1 : 52
82.9 C 2 112 224 3.73  0 : 3 : 44
Vol. Cat= 3 168 336 5.60  0 : 5 : 36



















PROPOSED MPV REDUCTION OF BENZAELDEHYDE 
MECHANISM 
Figure C.1 shows the proposed mechanism for the MPV reduction of 
benzadehyde using Al(OtBu)3,  including the quench step. 
 
 











H NMR DATA FOR AGGREGATION STATES OF CATALYSTS 
Figure D.1 shows 
1
H NMR for Al(OtBu)3 in benzene and Figure D.2 shows the 
1
H NMR for Al(OiPr)3 in isopropanol.  The rates of reaction between the two catalysts 
were attributed to their respective states of aggregation.  The Al(OtBu)3 catalysts exists as 
a cyclic dimer while the Al(OiPr)3 catalyst exists as a tetrameric complex.
[23]
  It has been 
previously suggested that only the non-bridging alkoxy groups can prefrom the hydrogen 
transfer required in the MPV reduction.
[24]
  Comparing the number on non-bridging to 
bridging groups of the two catalyst complexes, we expect the cyclic dimer to be more 




Proton integration is 1:2 for A to B
A
B
CH3 from free 
t-butyl alcohol 
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